COL1A2 and metabolic dysfunction-associated steatotic liver disease: Moreover, LIPA and COL1A2 expression showed a trend towards increasing in parallel with the degree of disease activity, with some significant intergroup differences when NAFLD cases were stratified according to NAS score (Fig. 5E).